PMS Study Ultravist-IMAGE, IoproMide (UltrAvist) to Gain Further Information on Tolerability and Safety in X-ray Examination
Information source: Bayer
ClinicalTrials.gov processed this data on August 23, 2015 Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Diagnostic Imaging
Intervention: Ultravist (Iopromide, BAY86-4877) (Drug)
Phase: N/A
Status: Completed
Sponsored by: Bayer Official(s) and/or principal investigator(s): Bayer Study Director, Study Director, Affiliation: Bayer
Summary
The purpose of this study is to obtain data on the safety and efficacy of Ultravist
application in usual daily use. The radiologist will administer the contrast medium to the
patient as he/she would have done without the study. No other examinations will be performed
than would have been done routinely.
Clinical Details
Official title: Post-marketing Surveillance Study Ultravist®-IMAGE IoproMide (UltrAvist®) to Gain Further Information on Tolerability and Safety in X-ray Examination
Study design: Observational Model: Cohort, Time Perspective: Prospective
Primary outcome: Occurrence of adverse events
Secondary outcome: General contrast quality in the region of interest as assessed by physicians
Eligibility
Minimum age: N/A.
Maximum age: N/A.
Gender(s): Both.
Criteria:
Inclusion Criteria:
- Patients with indication for an X-ray examination and for whom the radiologist has
decided to use the contrast medium Ultravist.
Exclusion Criteria:
- No exclusion criteria besides the contraindications for the use of Ultravist as
mentioned in the product information.
Locations and Contacts
Many Locations, Bosnia and Herzegovina
Many Locations, China
Many Locations, Germany
Many Locations, Hungary
Many Locations, Indonesia
Many Locations, Iran, Islamic Republic of
Many Locations, Italy
Many Locations, Korea, Republic of
Many Locations, Malaysia
Many Locations, Moldova, Republic of
Many Locations, Pakistan
Many Locations, Philippines
Many Locations, Poland
Many Locations, Romania
Many Locations, Russian Federation
Many Locations, Saudi Arabia
Many Locations, Singapore
Many Locations, Taiwan
Many Locations, Thailand
Many Locations, Ukraine
Many Locations, Vietnam
Additional Information
Click here and search for drug information provided by the FDA. Click here and search for information on any recalls, market or product safety alerts by the FDA which might have occurred with this product.
Starting date: March 2008
Last updated: February 25, 2011
|